Spectrum Pharmaceuticals Announces Data From Three Oncology,Programs Presented at the American Association of Cancer Research,Annual Meeting ( num family of compounds. Over the past ...)

HOME >> MEDICINE >> TECHNOLOGY

Spectrum Pharmaceuticals Announces Data From Three Oncology,Programs Presented at the American Association of Cancer Research,Annual Meeting

num family of compounds. Over the past two decades, platinum- based drugs have become a critical part of modern chemotherapy treatments and are used to treat a wide variety of cancers. Unlike the platinum drugs currently on the market, all of which require intravenous administration, satraplatin is an oral compound and is given as capsules that patients can take at home.

In addition to HRPC, satraplatin has been studied in clinical trials involving a range of tumors. Trials evaluating the effects of satraplatin in combination with radiation therapy, in combination with other cancer therapies and in a number of cancer types are underway or planned.

In 2002, Spectrum licensed the global rights to GPC Biotech . GPC Biotech is responsible for all costs associated with the development and regulatory filings of satraplatin. GPC Biotech has a co-development and license agreement with Pharmion GmbH, a wholly owned subsidiary of Pharmion Corporation, under which Pharmion has been granted exclusive commercialization rights to satraplatin for Europe and certain other territories. Spectrum licensed worldwide rights to satraplatin from Johnson Matthey PLC.

Satraplatin is a novel platinum analog with good oral bioavailability. A New Drug Application (NDA) for its initial indication, advanced hormone refractory prostate cancer, has recently been accepted by the FDA and given priority review status, with a date of August 15, 2007 for a decision regarding the approval of the NDA.

About SPI-1620

SPI-1620 is an endothelin B agonist that stimulates receptors on endothelial cells, the innermost layer of cells lining the blood vessels, to selectively dilate blood vessels in the tumor, resulting in a transient increase in blood flow and a consequent increase in the delivery of anti- cancer drugs to the tumor, as shown in animal studies to date. Tumors get their blood supply from blood vessels that are different from normal blood vessels and lack the surr
'"/>

Page: 1 2 3 4 5 6 7 8
Related medicine technology :

1. Merck at ASCO 2007: Spectrum of Studies Reinforces Promise of Erbitux for Colorectal and Head and Neck Cancer Patients
2. AEterna Zentaris Partner, Spectrum, Discloses Detailed Phase 2 Data for Ozarelix, in BPH at Annual AUA Meeting
3. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
7. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
8. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
9. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
10. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
11. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)

Post Your Comments:

(Date:12/15/2009)... ,, Reportlinker.com announces that a new market ... ,, Hepatitis B Vaccines - Pipeline ... ,, http://www.reportlinker.com/p0167309/Hepatitis-B-Vaccines---Pipeline-Analysis-and-Market-Forecasts-to-2015.html ,, Hepatitis B ... to 2015 ,, Summary ,, ... "Hepatitis B Vaccines - Pipeline Analysis and ...

(Date:12/15/2009)... Dec. 15 Reportlinker.com announces ... is available in its catalogue: ,, ... assessment of the competitive environment is ... management responsibilities, the task crucial to ... and factual competitive intelligence is vital ...

(Date:12/15/2009)... -- Reportlinker.com announces that a new ... its catalogue: ,, The Future ... to 2015, Competitive Benchmarking, Product Pipeline ... http://www.reportlinker.com/p0168102/The-Future-of-HIV-Therapeutics---Market-Forecasts-to-2015-Competitive-Benchmarking-Product-Pipeline-and-Deals-Analysis.html ,, Summary ... latest research "The Future of HIV ...

[0] Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 [0] Reportlinker Adds Top Ten World's Leading Orthopedics Companies [0] Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis

... May 29 Magellan Biosciences, an,emerging leader ... and assays designed to streamline microbiology testing,and ... 108th meeting of the,American Society for Microbiology ... Technologies, will share booth 743 at the,exhibition, ...

... Wyeth,Pharmaceuticals, a division of Wyeth (NYSE: ... Drug Administration (FDA) has issued an approvable letter ... of,adult patients with community-acquired pneumonia (CAP)., Before ... analyses to support the safety and efficacy of ...

Other Medicine Technology:Magellan Biosciences Companies to Feature Automated Products and New Tests for MRSA at the American Society for Microbiology Meeting, Booth 743 2 Magellan Biosciences Companies to Feature Automated Products and New Tests for MRSA at the American Society for Microbiology Meeting, Booth 743 3 Wyeth Receives Approvable Letter from FDA for TYGACIL for the Treatment of Patients with Community-Acquired Pneumonia 2 Wyeth Receives Approvable Letter from FDA for TYGACIL for the Treatment of Patients with Community-Acquired Pneumonia 3 Wyeth Receives Approvable Letter from FDA for TYGACIL for the Treatment of Patients with Community-Acquired Pneumonia 4 Wyeth Receives Approvable Letter from FDA for TYGACIL for the Treatment of Patients with Community-Acquired Pneumonia 5 Wyeth Receives Approvable Letter from FDA for TYGACIL for the Treatment of Patients with Community-Acquired Pneumonia 6

Magellan Biosciences Companies to Feature Automated Products and New Tests for MRSA at the American Society for Microbiology Meeting, Booth 743 Wyeth Receives Approvable Letter from FDA for TYGACIL for the Treatment of Patients with Community-Acquired Pneumonia

(Date:12/15/2009)... Dec. 15 Reportlinker.com announces ... is available in its catalogue: ,, ... Diseases Therapeutics - Market Forecasts to ... Deals Analysis ,, ... ,, The author has released its ...

(Date:12/15/2009)... Dec. 15 Today, Coastal Healthcare ... Clara County for the first time since ... Coastal Healthcare Administrators will be assuming responsibilities ... Physicians Foundation for Medical Care. ,, ... Coastal maintains close working relationships with all ...

(Date:12/15/2009)... to be the major form of the virus in ... Program (MHRP) researchers, however, have demonstrated that essentially all ... surface of red blood cells isolated from each of ... today in PLoS ONE , and can be ... Beck and Dr. Carl Alving, researchers with MHRP in ...

(Date:12/15/2009)... 2009Do good-looking people really benefit from their looks, and ... University of Georgia and the University of Kansas found ... social relationships and therefore an increased sense of psychological ... why we spend billions of dollars each year trying ... this month,s issue of Personal Relationships , also ...

(Date:12/15/2009)... Synthetic Fillers and Large Volume Injections Dangerous , ... ... -- The popularity and hype surrounding buttock augmentation and other ... outside U.S. borders is an alarming and potentially deadly trend, ... Permanent fillers such as polymethylmethacrylate (PMMA), silicone, and polyacrylimide used ...

[0] Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis [0] Coastal Healthcare Administrators Expands Provider Network to Santa Clara County [0] New insight into selective binding properties of infectious HIV [0] The importance of attractiveness depends on where you live [0] Physicians Coalition for Injectable Safety Warns Buttock-Boosting Injections Risky and Deadly

... Oak Brook , ... and the March of Dimes invites nurses, midwives, nurse practitioners, clinical ... the March of Dimes 34th Annual Perinatal Conference February 25-27th at ... professionals caring for moms and babies are urged to attend. , ...

... most common in India, leaves carriers with little warning of ... million people worldwide carry a gene mutation that almost always ... people in India, according to a study by 25 researchers ... of death in the world. By 2010, India will account ...

... have higher concentrations of folate in their blood than individuals ... at the University of California, San Francisco and UC Berkeley. ... patients with IBD are prone to folate also known ... that opens the door to additional research into the role ...

... condition has dropped , , FRIDAY, Jan. 23 (HealthDay News) ... distress syndrome (ARDS) hasn,t changed since 1994, according to ... a steady decline in the percentage of ARDS patients ... 1984 and 2006, and found the death rate for ...

... CALL TO ACTIONWASHINGTON, Jan. 23 The ... this country participating in volunteer events on Monday,s Martin ... the most popular Red Cross events were giving blood ... Ready." , , (Logo: http://www.newscom.com/cgi-bin/prnh/20090108/RedCrossLOGO ...

... AURORA, N.Y., Jan. 23 Moog Inc. (NYSE: MOG.A; ... of Ethox International for $15.2 million in cash. Ethox ... service provider. The company produces proprietary medical devices ... many of the industry,s leading medical device companies. Ethox ...

Other Medicine News:Health News:March of Dimes 34th Annual Perinatal Conference For Nurses, Health Educators, Social Workers and Other Healthcare Pros Caring for Moms and Babies 2 Health News:60 Million Worldwide Carry Heart Disease Mutation 2 Health News:Children with inflammatory bowel disease have surprisingly high folate levels, study finds 2 Health News:Children with inflammatory bowel disease have surprisingly high folate levels, study finds 3 Health News:Acute Respiratory Distress Syndrome as Deadly as Ever 2 Health News:Red Cross: Records Set On Day of Service 2 Health News:Moog Acquires Buffalo-Based Ethox International 2 Health News:Moog Acquires Buffalo-Based Ethox International 3 Health News:Moog Acquires Buffalo-Based Ethox International 4

March of Dimes 34th Annual Perinatal Conference For Nurses, Health Educators, Social Workers and Other Healthcare Pros Caring for Moms and Babies 60 Million Worldwide Carry Heart Disease Mutation Children with inflammatory bowel disease have surprisingly high folate levels, study finds Acute Respiratory Distress Syndrome as Deadly as Ever Red Cross: Records Set On Day of Service Moog Acquires Buffalo-Based Ethox International

Inquire...

500L...

... precision, ergonomics, and value!, Comfortable ... soft non-slip, contoured handle , Finer ... plunger spring action , Completely autoclavable ... the need for recalibration , Easy-to-read ...

Inquire...

Medicine Products:

Eppendorf Research Series 2100 Fixed-volume Pipette, 250 l Ovation BioNatural Pipette, one-stroke, fixed volume, 500L SoftGrip 500 L Fixed Volume Pipette Ovation BioNatural Pipette, two-stroke, fixed volume, 300L

( num family of compounds. Over the past ...)Spectrum Pharmaceuticals Announces Data From Three Oncology,Programs Presented at the American Association of Cancer Research,Annual Meeting,Health